Gerard Espinosa

52PUBLICATIONS
121CO-AUTHORS
AutoimmunityPredictive and prognostic markersCardiology (incl. cardiovascular diseases)Cardiovascular medicine and haematology not elsewhere classifiedOther biomedical and clinical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Jul 20, 2026
Impact of belimumab on the utility of serological markers for assessing systemic lupus erythematosus activity.

|Jun 15, 2026
Skin involvement in the catastrophic antiphospholipid syndrome: A review from CAPS registry.

|May 13, 2026
Changing Patterns in Hospitalisations of Patients with Systemic Lupus Erythematosus over Three Decades at a Tertiary Referral Centre in Catalonia.

|May 04, 2026
Belimumab in Systemic Lupus Erythematosus: From B-Cell Biology to Disease Modification.

|Feb 15, 2026
Anifrolumab Treatment in Cutaneous Lupus Erythematosus with and without systemic involvement: A Retrospective Study.

Xavier Bosch-Amate, Lluis Corbella-Bagot, Mariona Ayguasanosa

|Jan 29, 2026
Catastrophic antiphospholipid syndrome: Clinical characteristics and outcomes in a non-caucasian population - A five-year experience from a single centre.

Rodolfo Jiménez-Soto, María Espinosa-León, José Emilio Said-Diego

Pageof 9

Frequent Collaborators

29 joint publications

Ricard Cervera

8 joint publications

Ignasi Rodríguez-Pintó

7 joint publications

Olga Araújo

5 joint publications

José Hernández-Rodríguez